Method for reducing the risk of cancer among women with a hereditary predisposition to breast cancer by optimizing arsenic and selenium concentrations in the blood

PL451259A1Pending Publication Date: 2026-08-24READ GENE SPOKA AKCYJNA
4 Cites 0 Cited by

Patent Information

Application Number
PL2025451259
Authority / Receiving Office
PL · PL
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-02-21
Publication Date
2026-08-24
Patent Text Reader

Abstract

Unexpectedly, a correlation was found between the risk of cancer among women with a high hereditary predisposition to breast cancer who, depending on their selenium and arsenic levels, included or excluded specific foods from their diets or took selenium supplements to optimize their blood selenium and arsenic levels, and the concentration of selenium and arsenic in whole blood. This dietary intervention indicates a several-fold reduction / increase in the risk of cancer among women with an increased predisposition to breast cancer.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Method for determining the risk of cancers in women, who are the carriers of mutation in gene BRCA1 and BRCA2 in relation to concentration of arsenic, cadmium, zinc and / or selenium in the blood

    PL425603A1

  • Method of determining the risk of cancer in women depending on the ratio of selenium to arsenic concentrations in blood

    PL440972A1

  • Method of assessing the reduced risk of cancer in women under 50 years of age with a hereditary predisposition to breast cancer

    PL443075A1

  • Low-arsenic diet and the risk of cancer in women

    PL445013A1